Product safety spillovers and market viability for biologic drugs
Year of publication: |
June 2017
|
---|---|
Authors: | Romley, John ; Shih, Tiffany |
Published in: |
International journal of health economics and management. - New York, NY : Springer, ISSN 2199-9023, ZDB-ID 2799128-3. - Vol. 17.2017, 2, p. 135-158
|
Subject: | Pharmaceutical quality | Pharmaceutical competition | Pharmaceutical regulation | Biologic drugs | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Arzneimittelmarkt | Pharmaceutical market | Arzneimittelrecht | Pharmaceutical law | Pharmakologie | Pharmacology | Spillover-Effekt | Spillover effect | Produktqualität | Product quality | Industrieforschung | Industrial research |
-
Hemphill, Thomas A., (2013)
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
R&D and market size : who benefits from orphan drug legislation?
Gamba, Simona, (2021)
- More ...
-
Product Safety Spillovers and Market Viability for Biologic Drugs
Romley, John, (2015)
-
Shih, Tiffany, (2011)
-
Wright, Brian D., (2015)
- More ...